Advancing Personalised Care Congress 2022 Americas
Driving the Future of Medicine
Precision medicine (PM) is a medical model that proposes the customization of healthcare, with medical decisions, treatments, practices, or products being tailored to a subgroup of patients, instead of a one‐drug‐fits‐all model
Personalised medicine is a new tailored healthcare approach which is based on each patient’s unique genetic makeup as opposed to traditional medicine. It is a next-generation of treatment, which aims to advance the management of patients’ health by individualization to achieve the best outcomes in disease prevention, diagnosis, and treatment, and for the management of a patient’s condition, their predisposition to disease, and their prognosis. Following the development and deeper understanding of genetics and human genetic makeup, medical professionals are now able to develop safer and more effective treatment methods and drugs for various health conditions. This includes acquiring and examining patient health data to interpret scientific advances in disease research in order to enhance the quality of patient care.
Advancing Personalised Care Congress 2022 Americas, will focus on the “Driving the Future of Medicine”.
The Congress aims to look at the future of medicine in the digital age, the new challenges brought about by the pandemic, the role of technology moving forward, patient empowerment, ethical, social & legal issues surrounding patient information, cost, underdevelopment of technologies needed to meet the goals of precision medicine, lack of knowledge about molecular genetics and biochemistry, and reimbursement issues. We will explore how collective intelligence and collaborative leadership can drive innovation, as well as the need to change the culture in healthcare to be more patient-centered, participatory, and safety-focused.
According to Adroit Market Research, Personalized Medicine Market to Reach USD 800 Billion by 2028 at a CAGR of 7%. Massive advancements in companion diagnostics, improved funding schemes from private and public institutions along with technological development such as AI integration are steering large-scale growth in the personalized medicine market.
Although global personalized medicine is at a competitive edge, it is grappling with several challenges that are likely to hamper the growth of the global personalized medicine market. Nevertheless, rising interest in biomarkers, developments in genomic sequencing, expansion of precision medicine in health and healthcare areas, and advancements in biomarker analysis are promoting the development of the global personalized medicine market.
The two-day Congress will provide an interactive, cutting edge and comprehensive discussion and networking format led by international renowned speakers bringing their expertise on patient preferences, data harmonisation, implementation of personalised medicine into the healthcare system, collaboration between academia and industry, and the value of personalised medicine to patients.
We look forward to welcoming you to the congress!
Meet Our Professionals
Draft Program - Our Conference team are currently finalizing the program agenda.
No Spam - You will only receive relevant information on Personalized Medicine, and event updates
Group Discounts are also available.
what people say
Take Advantage of the Super Early Bird Discount. Group Discounts Also Available.
Supporting Companies Personalized Medicine.